Xenon Pharmaceuticals Inc
NASDAQ:XENE
Cash Flow Statement
Cash Flow Statement
Xenon Pharmaceuticals Inc
Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | ||||||||||||||||||||||||||||||||||||||||
Net Income |
11
|
21
|
13
|
2
|
2
|
(11)
|
(16)
|
(10)
|
(17)
|
(21)
|
(23)
|
(27)
|
(29)
|
(29)
|
(31)
|
(27)
|
(27)
|
(34)
|
(35)
|
(42)
|
(44)
|
(39)
|
(42)
|
(38)
|
(28)
|
(28)
|
(29)
|
(37)
|
(59)
|
(66)
|
(79)
|
(83)
|
(92)
|
(114)
|
(125)
|
(147)
|
(164)
|
(175)
|
(182)
|
|
Depreciation & Amortization |
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
3
|
4
|
|
Change in Deffered Taxes |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
Stock-Based Compensation |
1
|
1
|
1
|
6
|
4
|
3
|
4
|
(1)
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
3
|
3
|
3
|
2
|
2
|
2
|
3
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
10
|
12
|
14
|
17
|
20
|
23
|
26
|
29
|
0
|
|
Other Non-Cash Items |
1
|
1
|
1
|
9
|
6
|
9
|
11
|
1
|
3
|
1
|
1
|
3
|
3
|
1
|
1
|
(3)
|
(2)
|
(1)
|
(1)
|
3
|
3
|
3
|
3
|
4
|
5
|
6
|
6
|
7
|
8
|
10
|
11
|
16
|
20
|
26
|
26
|
23
|
23
|
22
|
28
|
|
Cash Interest Paid |
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Change in Working Capital |
(14)
|
(17)
|
(14)
|
(17)
|
(14)
|
(15)
|
(14)
|
(9)
|
(8)
|
(2)
|
2
|
3
|
3
|
0
|
1
|
(1)
|
(1)
|
0
|
0
|
3
|
3
|
4
|
34
|
24
|
11
|
6
|
(26)
|
(26)
|
(8)
|
(6)
|
(3)
|
(2)
|
(1)
|
(1)
|
(1)
|
8
|
8
|
7
|
6
|
|
Cash from Operating Activities |
(1)
N/A
|
6
N/A
|
0
-95%
|
(4)
N/A
|
(5)
-4%
|
(16)
-241%
|
(18)
-14%
|
(17)
+3%
|
(21)
-17%
|
(20)
+2%
|
(20)
+3%
|
(21)
-8%
|
(22)
-6%
|
(27)
-18%
|
(29)
-8%
|
(30)
-6%
|
(29)
+4%
|
(34)
-17%
|
(35)
-1%
|
(35)
-1%
|
(38)
-9%
|
(32)
+17%
|
(5)
+85%
|
(9)
-93%
|
(11)
-24%
|
(15)
-35%
|
(48)
-216%
|
(56)
-16%
|
(58)
-4%
|
(62)
-7%
|
(70)
-12%
|
(67)
+3%
|
(71)
-6%
|
(86)
-22%
|
(98)
-14%
|
(114)
-16%
|
(131)
-14%
|
(143)
-9%
|
(145)
-2%
|
|
Investing Cash Flow | ||||||||||||||||||||||||||||||||||||||||
Capital Expenditures |
(1)
|
(1)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(3)
|
(2)
|
(3)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(5)
|
(6)
|
(7)
|
(6)
|
|
Other Items |
(10)
|
(15)
|
(2)
|
(0)
|
(2)
|
13
|
11
|
9
|
(6)
|
(15)
|
(48)
|
(38)
|
(13)
|
(13)
|
25
|
20
|
13
|
(10)
|
(28)
|
(40)
|
(49)
|
(18)
|
(65)
|
(111)
|
(93)
|
(118)
|
(14)
|
(17)
|
(19)
|
14
|
(245)
|
(239)
|
(246)
|
(495)
|
(293)
|
(196)
|
(167)
|
116
|
(112)
|
|
Cash from Investing Activities |
(10)
N/A
|
(16)
-53%
|
(3)
+79%
|
(1)
+56%
|
(3)
-94%
|
11
N/A
|
10
-10%
|
9
-15%
|
(7)
N/A
|
(16)
-127%
|
(48)
-203%
|
(39)
+20%
|
(14)
+64%
|
(14)
+0%
|
24
N/A
|
20
-18%
|
13
-37%
|
(11)
N/A
|
(29)
-173%
|
(41)
-41%
|
(50)
-21%
|
(18)
+63%
|
(66)
-259%
|
(112)
-69%
|
(94)
+16%
|
(120)
-27%
|
(17)
+86%
|
(19)
-13%
|
(22)
-14%
|
12
N/A
|
(247)
N/A
|
(241)
+3%
|
(247)
-3%
|
(497)
-101%
|
(296)
+40%
|
(200)
+32%
|
(174)
+13%
|
108
N/A
|
(117)
N/A
|
|
Financing Cash Flow | ||||||||||||||||||||||||||||||||||||||||
Net Issuance of Common Stock |
0
|
0
|
43
|
43
|
43
|
43
|
0
|
0
|
0
|
24
|
24
|
24
|
24
|
0
|
0
|
0
|
29
|
103
|
103
|
103
|
74
|
0
|
28
|
130
|
130
|
130
|
103
|
119
|
119
|
124
|
448
|
337
|
606
|
602
|
278
|
271
|
1
|
30
|
354
|
|
Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
0
|
12
|
15
|
8
|
0
|
3
|
0
|
0
|
0
|
(17)
|
(17)
|
(17)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other |
(3)
|
(4)
|
(2)
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Cash from Financing Activities |
(3)
N/A
|
(4)
-17%
|
41
N/A
|
42
+1%
|
42
+1%
|
43
+1%
|
0
-99%
|
0
-32%
|
0
-21%
|
24
+15 873%
|
24
N/A
|
24
+1%
|
24
0%
|
0
-99%
|
7
+3 114%
|
7
-1%
|
41
+484%
|
118
+189%
|
112
-6%
|
112
0%
|
78
-30%
|
0
-100%
|
28
+22 833%
|
130
+372%
|
113
-13%
|
113
0%
|
86
-24%
|
102
+19%
|
119
+16%
|
124
+4%
|
448
+262%
|
337
-25%
|
606
+80%
|
602
-1%
|
278
-54%
|
271
-3%
|
1
-100%
|
30
+4 116%
|
354
+1 098%
|
|
Change in Cash | ||||||||||||||||||||||||||||||||||||||||
Effect of Foreign Exchange Rates |
(0)
|
(2)
|
(4)
|
(5)
|
(5)
|
(6)
|
(6)
|
(1)
|
(2)
|
1
|
2
|
(0)
|
0
|
1
|
1
|
0
|
(0)
|
(0)
|
(1)
|
(0)
|
0
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(1)
|
0
|
(0)
|
(1)
|
(1)
|
(0)
|
(1)
|
(3)
|
(2)
|
(3)
|
(1)
|
1
|
0
|
|
Net Change in Cash |
(15)
N/A
|
(16)
-9%
|
34
N/A
|
31
-9%
|
29
-5%
|
32
+8%
|
(13)
N/A
|
(10)
+26%
|
(29)
-196%
|
(11)
+61%
|
(42)
-267%
|
(36)
+14%
|
(12)
+66%
|
(39)
-225%
|
3
N/A
|
(3)
N/A
|
24
N/A
|
73
+201%
|
47
-35%
|
35
-26%
|
(10)
N/A
|
(50)
-386%
|
(43)
+15%
|
8
N/A
|
7
-14%
|
(23)
N/A
|
20
N/A
|
28
+36%
|
39
+41%
|
73
+88%
|
131
+80%
|
29
-78%
|
287
+905%
|
16
-95%
|
(118)
N/A
|
(47)
+60%
|
(305)
-550%
|
(4)
+99%
|
91
N/A
|
|
Free Cash Flow | ||||||||||||||||||||||||||||||||||||||||
Free Cash Flow |
(1)
N/A
|
5
N/A
|
(1)
N/A
|
(6)
-342%
|
(6)
-5%
|
(17)
-191%
|
(19)
-10%
|
(18)
+3%
|
(21)
-17%
|
(21)
+3%
|
(20)
+3%
|
(21)
-8%
|
(23)
-6%
|
(27)
-18%
|
(29)
-8%
|
(31)
-6%
|
(30)
+4%
|
(35)
-17%
|
(35)
-1%
|
(36)
-2%
|
(39)
-9%
|
(33)
+17%
|
(6)
+82%
|
(11)
-79%
|
(13)
-22%
|
(18)
-36%
|
(51)
-188%
|
(58)
-15%
|
(61)
-5%
|
(64)
-5%
|
(72)
-11%
|
(69)
+3%
|
(73)
-5%
|
(88)
-21%
|
(101)
-15%
|
(119)
-18%
|
(137)
-15%
|
(150)
-9%
|
(151)
-1%
|